In recent years, there has been a significant increase in the number of patients being prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a class of medications used to manage both type 2 diabetes and obesity ( 1 4 )
Once approved, we'll have clarity on: Which doses will be available The official dosing schedule and escalation protocol Prescribing guidelines and eligibility criteria NHS availability and private prescription options Until then, the information in this guide is based on clinical trial data and may differ from the final approved product
doi: 10.1016/j.addr.2022.114113 91 KrishnanNFangRHZhangL
399 Microvascular disease incidence over a 34-year period among Chinese with newly diagnosed diabetes and impaired glucose tolerance: the China Da Qing Diabetes and IGT Study 1986-2020 Q
Abhari K, Saadati S, Yari Z, et al
17.2 Safe Needle Disposal Used needles must be discarded in appropriate sharps containers to prevent injury and contamination